Inhibitors of HIV-1 attachment. Part 8: The effect of C7-heteroaryl substitution on the potency, and in vitro and in vivo profiles of indole-based inhibitors

被引:36
作者
Yeung, Kap-Sun [1 ]
Qiu, Zhilei [1 ]
Yin, Zhiwei [1 ]
Trehan, Ashok [1 ]
Fang, Haiquan [1 ]
Pearce, Bradley [1 ]
Yang, Zheng [1 ]
Zadjura, Lisa [1 ]
D'Arienzo, Celia J. [1 ]
Riccardi, Keith [1 ]
Shi, Pei-Yong [1 ]
Spicer, Timothy P. [1 ]
Gong, Yi-Fei [1 ]
Browning, Marc R. [1 ]
Hansel, Steven [1 ]
Santone, Kenneth [1 ]
Barker, Jonathan [2 ]
Coulter, Thomas [2 ]
Lin, Ping-Fang [1 ]
Meanwell, Nicholas A. [1 ]
Kadow, John F. [1 ]
机构
[1] Bristol Myers Squibb Res & Dev, Wallingford, CT 06492 USA
[2] Evotec UK Ltd, Abingdon OX14 4SA, Oxon, England
关键词
HIV-1 attachment inhibitors; Indole glyoxamide; Heterocycles; Ligand efficiency; Lipophilic ligand efficiency; MEDICINAL CHEMISTRY; DRUG DISCOVERY; PATTERNS; ENVELOPE; BINDING; ENTRY;
D O I
10.1016/j.bmcl.2012.10.117
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
As part of the SAR profiling of the indole-oxoacetic piperazinyl benzamide class of HIV-1 attachment inhibitors, substitution at the C7 position of the lead 4-fluoroindole 2 with various 5- and 6-membered heteroaryl moieties was explored. Highly potent (picomolar) inhibitors of pseudotyped HIV-1 in a primary, cell-based assay were identified and select examples were shown to possess nanomolar inhibitory activity against M-and T-tropic viruses in cell culture. These C7-heteroaryl-indole analogs maintained the ligand efficiency (LE) of 2 and were also lipophilic efficient as measured by LLE and LELP. Pharmacokinetic studies of this class of inhibitor in rats showed that several possessed substantially improved IV clearance and half-lives compared to 2. Oral exposure in the rat correlated with membrane permeability as measured in a Caco-2 assay where the highly permeable 1,2,4-oxadiazole analog 13 exhibited the highest exposure. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:203 / 208
页数:6
相关论文
共 28 条
  • [1] Oxadiazoles in Medicinal Chemistry
    Bostrom, Jonas
    Hogner, Anders
    Llinas, Antonio
    Wellner, Eric
    Plowright, Alleyn T.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (05) : 1817 - 1830
  • [2] Biotransformation reactions of five-membered aromatic heterocyclic rings
    Dalvie, DK
    Kalgutkar, AS
    Khojasteh-Bakht, SC
    Obach, RS
    O'Donnell, JP
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2002, 15 (03) : 269 - 299
  • [3] Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV
    De Clercq, Erik
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 (04) : 307 - 320
  • [4] The plasma membrane as a combat zone in the HIV battlefield
    Doms, RW
    Trono, D
    [J]. GENES & DEVELOPMENT, 2000, 14 (21) : 2677 - 2688
  • [5] Oxadiazole isomers: all bioisosteres are not created equal
    Goldberg, Kristin
    Groombridge, Sam
    Hudson, Julian
    Leach, Andrew G.
    MacFaul, Philip A.
    Pickup, Adrian
    Poultney, Ruth
    Scott, James S.
    Svensson, Per H.
    Sweeney, Joseph
    [J]. MEDCHEMCOMM, 2012, 3 (05) : 600 - 604
  • [6] Antiviral Activity, Pharmacokinetics, and Safety of BMS-488043, a Novel Oral Small-Molecule HIV-1 Attachment Inhibitor, in HIV-1-Infected Subjects
    Hanna, George J.
    Lalezari, Jacob
    Hellinger, James A.
    Wohl, David A.
    Nettles, Richard
    Persson, Anna
    Krystal, Mark
    Lin, Pinfang
    Colonno, Richard
    Grasela, Dennis M.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (02) : 722 - 728
  • [7] Envelope conformational changes induced by human immunodeficiency virus type 1 attachment inhibitors prevent CD4 binding and downstream entry events
    Ho, HT
    Fan, L
    Nowicka-Sans, B
    McAuliffe, B
    Li, CB
    Yamanaka, G
    Zhou, NN
    Fang, H
    Dicker, I
    Dalterio, R
    Gong, YF
    Wang, T
    Yin, ZW
    Ueda, Y
    Matiskella, J
    Kadow, J
    Clapham, P
    Robinson, J
    Colonno, R
    Lin, PF
    [J]. JOURNAL OF VIROLOGY, 2006, 80 (08) : 4017 - 4025
  • [8] Ligand efficiency: a useful metric for lead selection
    Hopkins, AL
    Groom, CR
    Alex, A
    [J]. DRUG DISCOVERY TODAY, 2004, 9 (10) : 430 - 431
  • [9] Kadow J. F, 2011, 241 ACS NAT M EXP AN
  • [10] Kadow J, 2006, CURR OPIN INVESTIG D, V7, P721